The Urinalysis Market report delivers a holistic analysis to understand the development scope and derive the growth rate for the forecast period. The report particularizes the market condition and forecasts the market size in the future. The report further studies the opportunities, influencers, driving factors, and limitations, by a thorough study of the leading market players of the Medical Devices industry from the different global region, their product/service types, and application markets. The prime aim of the report is to determine the revenue growth, market value, market share, CAGR, scope, challenges, growth promoters, etc.
Get a FREE Sample Copy of this Report with Graphs and Charts at: https://www.reportsnreports.com/contacts/requestsample.aspx?name=354105
The global urinalysis market size is projected to reach USD 4.9 billion by 2026 from USD 3.5 billion in 2021, at a CAGR of 7.2% during the forecast period.
Lists of Companies Profiled in the Report:
Siemens Healthineers AG (Germany)
F. Hoffmann-La Roche Ltd. (Switzerland)
Cardinal Health, Inc. (US)
Abbott Laboratories (US)
Danaher Corporation (US)
Sysmex Corporation (Japan)
Thermo Fisher Scientific Inc. (US)
Bio-Rad Laboratories, Inc. (US)
Becton, Dickinson and Company (US)
EKF Diagnostics (UK)
ARKRAY, Inc. (Japan)
ACON Laboratories, Inc. (US)
77 ElektronikaKft. (Hungary)
URIT Medical Electronic Group Co., Ltd. (China)
Dirui Industrial Co., Ltd. (China)
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
BIOBASE Group (China)
ERBA Mannheim (UK)
Teco Diagnostics (US)
Analyticon Technologies AG (Germany)
Bioway Biological Technology Co. Ltd. (China)
High Technology Inc. (US)
Agappe Diagnostics Ltd. (India)
Market growth is driven by factors such as increasing burden of UTIs, diabetes, and kidney & liver diseases, rising geriatric population and the subsequent increase in age- associated diseases and increasing adoption of POC diagnostic tests. On the other hand, availability of refurbished urine analyzers is expected to limit market growth to a certain extent in the coming years.
“The consumables accounted for the highest growth rate in the urinalysis market, byproduct, during the forecast period”
The urinalysis market is segmented into consumables and instruments. The consumables segment accounted for the highest growth rate in the urinalysis market in 2020. The requirement of consumables in large numbers compared to instruments is the main factor contributing to this segment’s high growth rate. This segment’s market growth can also be attributed to repeat purchases of consumables compared to instruments.
“Disease screening segment accounted for the highest CAGR”
Based on the application, the urinalysis market is segmented into disease screening and pregnancy & fertility. In 2020, the disease screening segment accounted for the highest CAGR. The increasing incidence of UTIs and kidney ailments worldwide are driving the growth of this market.
“Diagnostic Laboratories segment accounted for the highest CAGR”
Based on end-users, the urinalysis market is segmented into diagnostic laboratories, hospitals and clinics, home care settings and research laboratories & institutes. In 2020, the diagnostic laboratories segment accounted for the highest CAGR. This can be attributed to rapidly growing aging population, the increasing global incidence of kidney diseases and UTIs, increase in reimbursements for clinical tests performed in hospitals, and the launch of advanced urinalysis devices such as integrated devices.
“Asia Pacific: The fastest-growing region urinalysis market”
The global urinalysis market is segmented into North America, Europe, Asia Pacific, and Rest of the World. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Factors such rising geriatric population, high burden of chronic diseases such as CKD, growing per capita income, increasing investments in the healthcare industry by key market players, expansion of private-sector hospitals to rural areas in various APAC countries, an increasing number of hospitals and clinics, and the presence of high-growth markets are driving the growth of the urinalysis market in this region.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type: Tier 1 – 40%, Tier 2 – 30%,and Tier 3 -30%
- By Designation: C-level – 27%, D-level – 18%, and Others – 55%
- By Region: North America -51%, Europe – 21%, Asia Pacific – 18%, and Rest of the World – 10%
This report provides a detailed picture of the global urinalysis market. It aims at estimating the size and future growth potential of the market across different segments, such as product, test type, application, end user, and region. The report also includes in-depth competitive analysis ofthe key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall urinalysis market and its sub-segments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, challenges, and opportunities.
Get 20% Discount on this Research Report at: https://www.reportsnreports.com/contacts/discount.aspx?name=354105https://jumbonews.co.uk/